These studies suggest therapies designed to restore numbers and function of immune cells other than CD4 T cells may be beneficial for reestablishing the balance of CD4 T cell subsets following sepsis and for reducing the effects of increased Treg representation. The gene discussed is CD4; the disease is Sepsis.